国：米国 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
米国 (1011)
- {{country.name}}
- すべての国
- 米国 (1011)
- オーストラリア (58)
- オーストリア (16)
- ベルギー (7)
- ブラジル (16)
- カナダ (83)
- 中国 (94)
- デンマーク (6)
- フィンランド (4)
- フランス (41)
- ドイツ (737)
- 香港 (46)
- インド (19)
- アイルランド (1)
- イスラエル (19)
- イタリア (4)
- 日本 (37)
- メキシコ (28)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (14)
- ポーランド (9)
- ロシア (2)
- 韓国 (10)
- スペイン (4)
- スウェーデン (70)
- スイス (11)
- 台湾 (67)
- タイ (2)
- トルコ (1)
- イギリス (69)
全取引所
バイオテクノロジー (1011)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S NVO | $109.66 — |
+0.42
|
$489.22B — | $2.39M — | $109.14 — | $110.52 — | $489.22B — | 36.79 | $2.98 — | |
| Novo Nordisk A/S NONOF | $109.35 — |
+0.32
|
$488.74B — | $6 — | $109.35 — | $109.35 — | $488.74B — | 36.57 | $2.99 — | |
| Vertex Pharmaceuticals Incorporated VRTX | $458.23 — |
+0.28
|
$118.01B — | $607.8K — | $450 — | $461.76 — | $118.01B — | 0 | -$1.92 — | |
| CSL Limited CSLLY | $91.03 — |
-0.51
|
$88.73B — | $106 — | $91.03 — | $91.04 — | $88.73B — | 33.34 | $2.73 — | |
| Regeneron Pharmaceuticals REGN | $750.59 — |
+0.14
|
$82.48B — | $220.53K — | $744.14 — | $752.75 — | $82.48B — | 18.57 | $40.4 — | |
| argenx SE ARGX | $618.52 — |
+1.99
|
$37.92B — | $127.22K — | $608.2 — | $622.88 — | $37.92B — | 0 | -$0.79 — | |
| UCB SA UCBJY | $99.2 — |
+0.06
|
$37.64B — | $1.15K — | $98.85 — | $99.51 — | $37.64B — | 155.00 | $0.64 — | |
| Alnylam Pharmaceuticals ALNY | $255.06 — |
+1.28
|
$32.9B — | $186.24K — | $250.35 — | $256.68 — | $32.9B — | 0 | -$2.62 — | |
| BioNTech SE BNTX | $115.03 — |
-0.49
|
$27.58B — | $166K — | $114.04 — | $116.98 — | $27.58B — | 0 | -$2.03 — | |
| BeiGene BGNE | $201.68 — |
-2.1
|
$22.42B — | $99.51K — | $200.6 — | $206.43 — | $22.42B — | 0 | -$8.2 — | |
| United Therapeutics UTHR | $371.87 — |
+0.84
|
$16.6B — | $53.56K — | $367.94 — | $374 — | $16.6B — | 16.34 | $22.75 — | |
| Moderna MRNA | $41.89 — |
-1.62
|
$16.12B — | $2.65M — | $41.48 — | $42.8 — | $16.12B — | 0 | -$5.81 — | |
| Royalty Pharma RPRX | $26.14 — |
-0.76
|
$15.4B — | $1.07M — | $26.13 — | $26.35 — | $15.4B — | 10.29 | $2.54 — | |
| Incyte INCY | $73.93 — |
+2.64
|
$14.24B — | $1.41M — | $73.34 — | $75.32 — | $14.24B — | 821.44 | $0.09 — | |
| Genmab A/S GMAB | $21.64 — |
-0.28
|
$13.89B — | $260.22K — | $21.55 — | $21.71 — | $13.89B — | 21.21 | $1.02 — | |
| Genmab A/S GNMSF | $209.25 — |
-8.74
|
$13.65B — | $2 — | $209.25 — | $209.25 — | $13.65B — | 20.55 | $10.18 — | |
| Insmed Incorporated INSM | $74.3 — |
+2.57
|
$13.29B — | $405.93K — | $71.75 — | $74.98 — | $13.29B — | 0 | -$5.55 — | |
| Summit Therapeutics SMMT | $17.39 — |
-2.14
|
$12.82B — | $959.1K — | $17.29 — | $17.84 — | $12.82B — | 0 | -$0.23 — | |
| BioMarin Pharmaceutical BMRN | $65.69 — |
+3.95
|
$12.52B — | $1.41M — | $62.85 — | $66.38 — | $12.52B — | 39.56 | $1.66 — | |
| Bio-Techne TECH | $76.09 — |
+1.39
|
$12.09B — | $196.93K — | $73.79 — | $76.81 — | $12.09B — | 80.09 | $0.95 — | |
| Sarepta Therapeutics SRPT | $126.44 — |
+0.34
|
$12.08B — | $196.48K — | $124.81 — | $127.96 — | $12.08B — | 82.10 | $1.54 — | |
| Vaxcyte PCVX | $92.35 — |
+2.18
|
$11.51B — | $269.91K — | $89.58 — | $93.05 — | $11.51B — | 0 | -$4.6 — | |
| Exelixis EXEL | $35.42 — |
+0.45
|
$10.12B — | $547.26K — | $35.08 — | $35.56 — | $10.12B — | 22.85 | $1.55 — | |
| Roivant Sciences ROIV | $12.1 — |
-0.17
|
$8.81B — | $3.65M — | $12.06 — | $12.26 — | $8.81B — | 2.18 | $5.54 — | |
| WuXi Biologics (Cayman) WXXWY | $4.2 — |
-0.71
|
$8.75B — | $5.65K — | $4.2 — | $4.21 — | $8.75B — | 24.70 | $0.17 — | |
| Revolution Medicines RVMD | $48.73 — |
+1.04
|
$8.2B — | $4.08M — | $46.33 — | $49.88 — | $8.2B — | 0 | -$3.66 — | |
| Legend Biotech LEGN | $43.94 — |
+0.6
|
$8.06B — | $611.66K — | $43.5 — | $44.53 — | $8.06B — | 0 | -$1.92 — | |
| Innovent Biologics IVBXF | $4.85 — |
0
|
$7.95B — | $674 — | $5.9 — | $5.9 — | $7.95B — | 0 | -$0.11 — | |
| Ascendis Pharma A/S ASND | $130.19 — |
-0.88
|
$7.78B — | $180.14K — | $129.28 — | $132.28 — | $7.78B — | 0 | -$7.83 — | |
| Jazz Pharmaceuticals JAZZ | $123.2 — |
+1.28
|
$7.45B — | $125.62K — | $120.84 — | $123.2 — | $7.45B — | 17.44 | $7.06 — | |
| Madrigal Pharmaceuticals MDGL | $318.36 — |
-0.93
|
$6.94B — | $112.47K — | $317.32 — | $327.53 — | $6.94B — | 0 | -$25.03 — | |
| Nuvalent NUVL | $94.86 — |
+0.11
|
$6.74B — | $90.87K — | $94.16 — | $97.02 — | $6.74B — | 0 | -$3.49 — | |
| Corcept Therapeutics Incorporated CORT | $61.25 — |
+2.64
|
$6.42B — | $373.52K — | $59.53 — | $62.2 — | $6.42B — | 48.60 | $1.26 — | |
| Halozyme Therapeutics HALO | $48.76 — |
+0.58
|
$6.2B — | $264.44K — | $48.43 — | $49.08 — | $6.2B — | 16.14 | $3.02 — | |
| Blueprint Medicines BPMC | $96.24 — |
-0.3
|
$6.11B — | $128.44K — | $96.04 — | $98.48 — | $6.11B — | 0 | -$2.09 — | |
| Cytokinetics, Incorporated CYTK | $50.6 — |
-1.77
|
$5.97B — | $261.24K — | $50.51 — | $51.53 — | $5.97B — | 0 | -$5.38 — | |
| Ionis Pharmaceuticals IONS | $36.53 — |
+2.01
|
$5.77B — | $249.49K — | $35.44 — | $36.72 — | $5.77B — | 0 | -$2.44 — | |
| Viking Therapeutics VKTX | $49.88 — |
-0.76
|
$5.56B — | $1.36M — | $49.5 — | $50.69 — | $5.56B — | 0 | -$0.94 — | |
| Krystal Biotech KRYS | $187.58 — |
+0.86
|
$5.39B — | $104.5K — | $186.27 — | $190.4 — | $5.39B — | 104.79 | $1.79 — | |
| Crinetics Pharmaceuticals CRNX | $57.88 — |
+2.28
|
$5.37B — | $211.34K — | $56.45 — | $58.93 — | $5.37B — | 0 | -$3.7 — | |
| BridgeBio Pharma BBIO | $27.64 — |
+3.99
|
$5.22B — | $734.53K — | $26.3 — | $27.8 — | $5.22B — | 0 | -$2.42 — | |
| TG Therapeutics TGTX | $33.37 — |
-0.07
|
$5.19B — | $760.16K — | $33.3 — | $34.33 — | $5.19B — | 0 | -$0.1 — | |
| Axsome Therapeutics AXSM | $99.98 — |
-0.51
|
$4.85B — | $178K — | $99.83 — | $102.31 — | $4.85B — | 0 | -$6.58 — | |
| Arcellx ACLX | $88.03 — |
-0.7
|
$4.76B — | $103.69K — | $87.06 — | $90.27 — | $4.76B — | 0 | -$0.71 — | |
| Biohaven BHVN | $46.74 — |
+7.01
|
$4.73B — | $239.82K — | $43.73 — | $47.42 — | $4.73B — | 0 | -$9.37 — | |
| ADMA Biologics ADMA | $19.63 — |
-1.46
|
$4.64B — | $588.76K — | $19.61 — | $19.99 — | $4.64B — | 72.70 | $0.27 — | |
| Avidity Biosciences RNA | $38.42 — |
-0.17
|
$4.58B — | $518.22K — | $38.02 — | $39.57 — | $4.58B — | 0 | -$2.88 — | |
| CRISPR Therapeutics AG CRSP | $51.61 — |
+0.72
|
$4.41B — | $670.65K — | $50.54 — | $52.29 — | $4.41B — | 0 | -$2.79 — | |
| Ultragenyx Pharmaceutical RARE | $47.41 — |
+1.59
|
$4.38B — | $139.94K — | $46.4 — | $48.22 — | $4.38B — | 0 | -$6.35 — | |
| Apellis Pharmaceuticals APLS | $34.15 — |
-1.39
|
$4.25B — | $370.07K — | $33.9 — | $34.76 — | $4.25B — | 0 | -$2.03 — | |
| Immunovant IMVT | $28.92 — |
+2.46
|
$4.24B — | $112.04K — | $28.1 — | $28.98 — | $4.24B — | 0 | -$2.21 — | |
| PTC Therapeutics PTCT | $50.16 — |
-0.26
|
$3.87B — | $384.94K — | $49.84 — | $51.62 — | $3.87B — | 0 | -$5.94 — | |
| Rhythm Pharmaceuticals RYTM | $60.43 — |
+0.57
|
$3.71B — | $232.64K — | $59.67 — | $60.9 — | $3.71B — | 0 | -$4.32 — | |
| Scholar Rock Holding SRRK | $39.62 — |
+0.61
|
$3.71B — | $599.86K — | $38.71 — | $40.87 — | $3.71B — | 0 | -$2.36 — | |
| Janux Therapeutics JANX | $66.22 — |
+10.62
|
$3.48B — | $2.35M — | $57 — | $67.96 — | $3.48B — | 0 | -$1.17 — | |
| Agios Pharmaceuticals AGIO | $60.22 — |
+2.27
|
$3.43B — | $258.6K — | $57.91 — | $62.15 — | $3.43B — | 5.16 | $11.66 — | |
| Denali Therapeutics DNLI | $23.76 — |
-0.57
|
$3.42B — | $206.2K — | $23.62 — | $24.08 — | $3.42B — | 0 | -$2.76 — | |
| Veracyte VCYT | $43.88 — |
+0.51
|
$3.4B — | $159.97K — | $43.01 — | $44.5 — | $3.4B — | 0 | -$0.13 — | |
| ImmunityBio IBRX | $4.68 — |
+2.63
|
$3.26B — | $1.4M — | $4.58 — | $4.75 — | $3.26B — | 0 | -$0.9 — | |
| SpringWorks Therapeutics SWTX | $43.42 — |
+2.04
|
$3.23B — | $624.06K — | $42.3 — | $44.92 — | $3.23B — | 0 | -$3.89 — | |
| Xenon Pharmaceuticals XENE | $42.3 — |
+0.71
|
$3.22B — | $98.23K — | $41.84 — | $43 — | $3.22B — | 0 | -$2.81 — | |
| Verona Pharma VRNA | $39.4 — |
+1.92
|
$3.22B — | $341.94K — | $38.49 — | $39.98 — | $3.22B — | 0 | -$2 — | |
| Merus MRUS | $46.4 — |
+0.41
|
$3.18B — | $226.87K — | $45.96 — | $46.87 — | $3.18B — | 0 | -$4.03 — | |
| Vera Therapeutics VERA | $49.53 — |
+0.3
|
$3.14B — | $149.02K — | $49.29 — | $50.37 — | $3.14B — | 0 | -$2.61 — | |
| Zai Lab ZLAB | $28.45 — |
-5.67
|
$3.06B — | $540.12K — | $28.26 — | $29.75 — | $3.06B — | 0 | -$2.8 — | |
| Edgewise Therapeutics EWTX | $32 — |
+0.13
|
$3.03B — | $453.69K — | $31.77 — | $32.82 — | $3.03B — | 0 | -$1.5 — | |
| Kymera Therapeutics KYMR | $45.88 — |
-2.2
|
$2.97B — | $71.27K — | $45.85 — | $47.36 — | $2.97B — | 0 | -$2.34 — | |
| Dyne Therapeutics DYN | $29.1 — |
+3.28
|
$2.96B — | $241.28K — | $27.93 — | $29.52 — | $2.96B — | 0 | -$3.58 — | |
| Amicus Therapeutics FOLD | $9.89 — |
+0.97
|
$2.95B — | $634.17K — | $9.75 — | $9.99 — | $2.95B — | 0 | -$0.34 — | |
| Vericel VCEL | $59.69 — |
+2.48
|
$2.95B — | $121.83K — | $57.8 — | $59.85 — | $2.95B — | 746.06 | $0.08 — | |
| Arrowhead Pharmaceuticals ARWR | $23.61 — |
-9.44
|
$2.94B — | $1.28M — | $23.6 — | $26.38 — | $2.94B — | 0 | -$5 — | |
| Recursion Pharmaceuticals RXRX | $7.29 — |
+2.75
|
$2.83B — | $5.38M — | $7.02 — | $7.45 — | $2.83B — | 0 | -$1.54 — | |
| ACADIA Pharmaceuticals ACAD | $17 — |
+4.29
|
$2.83B — | $722.7K — | $16.3 — | $17.26 — | $2.83B — | 21.79 | $0.78 — | |
| Iovance Biotherapeutics IOVA | $8.81 — |
+0.86
|
$2.68B — | $1.32M — | $8.65 — | $8.9 — | $2.68B — | 0 | -$1.48 — | |
| Keros Therapeutics KROS | $64.85 — |
+4.13
|
$2.63B — | $191.84K — | $62.77 — | $66.23 — | $2.63B — | 0 | -$5.22 — | |
| Catalyst Pharmaceuticals CPRX | $21.92 — |
+0.99
|
$2.62B — | $241.23K — | $21.56 — | $22.05 — | $2.62B — | 18.58 | $1.18 — | |
| Protagonist Therapeutics PTGX | $40.8 — |
-1.09
|
$2.43B — | $313.39K — | $40.6 — | $42.18 — | $2.43B — | 14.89 | $2.74 — | |
| Geron GERN | $4.01 — |
+1.39
|
$2.42B — | $1.38M — | $3.91 — | $4.08 — | $2.42B — | 0 | -$0.32 — | |
| IDEAYA Biosciences IDYA | $27.85 — |
+4.44
|
$2.41B — | $326.88K — | $26.4 — | $27.9 — | $2.41B — | 0 | -$2.33 — | |
| Longboard Pharmaceuticals LBPH | $59.98 — |
0
|
$2.34B — | $655.8K — | $59.98 — | $59.98 — | $2.34B — | 0 | -$2.25 — | |
| Ligand Pharmaceuticals Incorporated LGND | $121.24 — |
+1.09
|
$2.29B — | $25.15K — | $119.95 — | $123 — | $2.29B — | 48.69 | $2.49 — | |
| Centessa Pharmaceuticals CNTA | $17.26 — |
+0.79
|
$2.27B — | $64.91K — | $16.92 — | $17.48 — | $2.27B — | 0 | -$1.52 — | |
| Mirum Pharmaceuticals MIRM | $46.24 — |
+1.44
|
$2.22B — | $69.07K — | $45.63 — | $46.76 — | $2.22B — | 0 | -$2.08 — | |
| Bavarian Nordic A/S BVNRY | $8.96 — |
+2.75
|
$2.21B — | $10.38K — | $8.94 — | $9.06 — | $2.21B — | 13.17 | $0.68 — | |
| Wave Life Sciences WVE | $14.46 — |
+2.96
|
$2.2B — | $345.61K — | $13.98 — | $14.68 — | $2.2B — | 0 | -$1.12 — | |
| Soleno Therapeutics SLNO | $50.94 — |
-0.43
|
$2.2B — | $261.86K — | $50.93 — | $52.42 — | $2.2B — | 0 | -$2.79 — | |
| Beam Therapeutics BEAM | $26.49 — |
+1.96
|
$2.19B — | $238.08K — | $25.68 — | $27.12 — | $2.19B — | 0 | -$1.58 — | |
| Akero Therapeutics AKRO | $31.04 — |
+0.93
|
$2.17B — | $205.99K — | $30.44 — | $31.39 — | $2.17B — | 0 | -$3.78 — | |
| Harmony Biosciences HRMY | $34.81 — |
+0.9
|
$1.99B — | $89.47K — | $34.5 — | $35.35 — | $1.99B — | 16.49 | $2.11 — | |
| Tarsus Pharmaceuticals TARS | $50.45 — |
+0.1
|
$1.93B — | $115.37K — | $50.35 — | $52.13 — | $1.93B — | 0 | -$3.75 — | |
| Oxford Nanopore ONTTF | $1.96 — |
-4.85
|
$1.89B — | $1.82K — | $1.96 — | $1.96 — | $1.89B — | 0 | -$0.25 — | |
| Xencor XNCR | $26.57 — |
-0.11
|
$1.86B — | $269.75K — | $26.34 — | $27.24 — | $1.86B — | 0 | -$3.18 — | |
| MannKind MNKD | $6.7 — |
-0.15
|
$1.85B — | $877.79K — | $6.59 — | $6.77 — | $1.85B — | 83.75 | $0.08 — | |
| Celldex Therapeutics CLDX | $27.26 — |
+3.95
|
$1.81B — | $304.64K — | $26.19 — | $28.65 — | $1.81B — | 0 | -$2.58 — | |
| Galapagos GLPG | $27.07 — |
-1.53
|
$1.8B — | $38.67K — | $26.95 — | $27.3 — | $1.8B — | 0 | -$0.96 — | |
| Arvinas ARVN | $24.73 — |
+2.23
|
$1.7B — | $369.78K — | $23.82 — | $24.82 — | $1.7B — | 0 | -$4.79 — | |
| Travere Therapeutics TVTX | $19.51 — |
+0.67
|
$1.7B — | $205.2K — | $19.18 — | $19.75 — | $1.7B — | 0 | -$4.52 — | |
| Viridian Therapeutics VRDN | $20.17 — |
+0.4
|
$1.6B — | $777.8K — | $19.88 — | $20.56 — | $1.6B — | 0 | -$4.32 — | |
| Immunocore IMCR | $31.8 — |
-1.3
|
$1.59B — | $117.75K — | $31.23 — | $32.66 — | $1.59B — | 0 | -$0.95 — | |
| Arcus Biosciences RCUS | $17.15 — |
+4.32
|
$1.57B — | $304.5K — | $16.05 — | $17.43 — | $1.57B — | 0 | -$3.19 — | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||